Thomas Hwang

affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

220

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Biosimilar Entry and the Pricing of Biologic Drugs

Number of pages: 49 Posted: 01 Feb 2021
Luca Maini, Josh Feng, Thomas Hwang and Jacob Klimek
UNC Chapel Hill, University of Utah - David Eccles School of Business, affiliation not provided to SSRN and University of North Carolina at Chapel Hill
Downloads 139 (257,548)

Abstract:

Loading...

Biosimilars, Drug Pricing

2.

Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid

Number of pages: 40 Posted: 20 Mar 2020 Last Revised: 16 Apr 2021
Josh Feng, Thomas Hwang and Luca Maini
University of Utah - David Eccles School of Business, affiliation not provided to SSRN and UNC Chapel Hill
Downloads 81 (371,709)
Citation 1

Abstract:

Loading...

Medicaid, Pharmaceutical Market, Bargaining, Most-Favored Customer Clauses, Procurement